drugset / Trial / NCT01560234

AZD8848 Single Ascending Dose Study

NCT01560234 ↗

Phase 1 Completed 47 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindBasic science

Summary

This study will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of AZD8848 in healthy subjects.

Timeline

Start
2012-05
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8848 Small molecule — Inhaled

Indications

No indication recorded.